Genetic Testing: Are We Moving Too Fast?

The rapid advancements in genetic testing are sparking a crucial debate: are we progressing too quickly, potentially exacerbating existing societal inequalities? Daphne O. Martschenko and Sam Trejo, despite sharing a desire for a fairer world, hold differing views on whether exploring social genomics – the study of genetic contributions to behaviors like mental health, education, and political leanings – will help achieve this goal. This article delves into their perspectives, the ethical considerations, and the latest developments in this rapidly evolving field, examining the potential benefits and risks of widespread genetic testing.

The Core of the Debate: Progress vs. Peril

Martschenko argues that genetic research has historically been used to justify and reinforce existing social disparities. She believes that we already know the solutions to many injustices – such as poverty alleviation – and that further genetic research is unnecessary for their implementation. Conversely, Trejo contends that more information is generally beneficial. He posits that the potential benefits of basic research are unpredictable, and since this research is happening regardless, we should strive to harness it for good.

Their collaborative work, documented in “What We Inherit: How New Technologies and Old Myths Are Shaping Our Genomic Future,” exemplifies an “adversarial collaboration” – a constructive dialogue between opposing viewpoints. This approach highlights the value of understanding diverse perspectives in navigating complex ethical and scientific challenges.

Unpacking the Genetic Myths

Trejo, a quantitative sociologist from Princeton, and Martschenko, a qualitative bioethicist at Stanford, identified two key “genetic myths” that fuel the debate. The first is the Destiny Myth, popularized by Francis Galton in 1869, which incorrectly separates the influence of DNA from the environment. Galton erroneously pitted nature against nurture, failing to recognize their interconnectedness. This idea tragically culminated in the eugenics movement and the horrific policies of Nazi Germany.

The second myth is the Race Myth – the false belief that humans can be divided into distinct biological racial groups based on genetic differences. While ancestry can be traced genetically, it doesn’t equate to biologically defined racial categories. The authors primarily focus on polygenic scores, which aggregate the impact of numerous small genetic influences, exploring their potential, limitations, and the need for responsible regulation.

Polygenic Scores: A Deep Dive

Polygenic scores attempt to predict traits like height, depression, or heart disease by summing the contributions of many genes, each with a minor effect. It’s crucial to understand that these scores are probabilistic, not deterministic. They indicate a predisposition, not a guaranteed outcome, as environmental factors play a significant role. They can’t definitively predict someone’s future, only suggest a slightly increased or decreased likelihood of certain outcomes.

Limitations and Inaccuracies

Despite their potential, polygenic scores have several limitations:

• Accuracy: They are inherently not highly accurate.
• Trait Correlation: Accuracy decreases when predicting multiple traits simultaneously.
• Ancestral Bias: They are significantly less accurate for individuals of non-European descent, due to the historical focus of genetic studies on European populations.

This ancestral bias raises serious concerns about equitable access and potential for exacerbating existing health disparities. Any benefits derived from this technology will likely be unevenly distributed, favoring those with European ancestry.

Regulation and the Backdoor to Genetic Selection

Martschenko and Trejo emphasize the urgent need for stricter regulation of the generation, sale, and use of polygenic scores. They warn that while attention is focused on gene editing, genetic embryo selection using polygenic scores is progressing largely unchecked. “While scientists and policymakers are guarding the front gate against gene editing, genetic embryo selection (using polygenic scores) is slipping in through the backdoor,” they write.

Currently, IVF patients can already select embryos based on gender and the presence of clear genetic markers for serious diseases. Now, they can potentially choose embryos based on polygenic scores, raising ethical concerns about designer babies and the creation of a genetic elite.

The Rise of Commercial Genetic Screening

In 2020, Genomic Prediction began offering genomic scores for traits like diabetes, skin cancer, and even “idiopathic short stature” (though they later discontinued advertising the latter due to controversy). Another company, Herasight, now offers embryo selection based on intelligence. The more traits selected for, the less accurate each prediction becomes, and the potential for unintended consequences increases.

Furthermore, many genes influence multiple biological processes, meaning selecting for one desirable trait could inadvertently impact others negatively. Ignoring the environmental impact is also a critical oversight. Simple lifestyle changes, like a healthy diet and exercise, often have a greater impact than minor genetic predispositions.

The Risk of Reduced Genetic Diversity

The authors fear that widespread embryonic selection based on polygenic scores could lead to a new form of social inequality. Unlike interventions like growth hormones or tutoring, which affect only individuals, genetic selection impacts future generations. This could create a class of “optimized” individuals whose status is based on genetic advantages, regardless of their actual capabilities.

Reducing genetic diversity also poses a threat to humanity as a whole. Exposure to diverse perspectives and experiences is essential for societal progress. A homogenous population, bred for specific traits, could stifle innovation and limit our ability to adapt to future challenges. Everyone can benefit from exposure to people who are different from them; if everyone is bred to be tall, smart, and good-looking, how will we learn to tolerate otherness?

Current Regulatory Landscape and Future Outlook

Polygenic embryo selection is currently illegal in the UK, Israel, and much of Europe. In 2024, the FDA in the US signaled intentions to regulate the market, but currently, companies offering polygenic scores operate under the same unregulated category as nutritional supplements. These companies advertise scores for traits like musical ability and acrophobia, often framing them as “wellness” or “educational” tools.

This leaves Americans largely vulnerable to corporations prioritizing profit over responsible innovation. Wealthy individuals with European ancestry are often the only ones who can afford to access these technologies, further entrenching existing inequalities and potentially creating new genetic disparities. Ideally, increased data collection and research will eventually lead to more reliable polygenic scores that are accessible to everyone, but that future remains uncertain.

The Path Forward: Responsible Innovation

The debate surrounding genetic testing is complex and multifaceted. While the potential benefits are undeniable, the ethical and societal risks are equally significant. A cautious and regulated approach is crucial, prioritizing equitable access, protecting genetic diversity, and ensuring that these powerful technologies are used responsibly. The conversation sparked by Martschenko and Trejo’s work is a vital step towards navigating this challenging landscape and shaping a future where genetic advancements benefit all of humanity, not just a privileged few. The key lies in fostering open dialogue, promoting scientific literacy, and establishing robust ethical guidelines to prevent the misuse of genetic information and ensure a fairer, more equitable future.